DNAstack launches Neuroscience AI to accelerate collaborative research and discovery
Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.
Our software connects a global community of precision medicine initiatives, research consortiums, patient advocacy groups, hospitals, startups, funders, pharma companies, and governments to accelerate collaborative discoveries in genomics and health.
Our integrated product suite empowers data custodians to connect, protect, share, and measure the impact of their data and make it easier for researchers to find, access, and use it to power breakthrough discoveries in genomics and precision health.
DNAstack is leading the development of Canadian Platform for Genomics & Precision Health
Technology Pioneer
DNAstack was selected for establishing federated data networks and powering insights in pandemic surveillance, neuroscience, rare disease, and oncology.
Company of the Year
The award celebrates DNAstack’s breakthrough software platform, which enables AI-powered insights across distributed genomics and health data.
DNAstack powers genomic variant surveillance of SARS-CoV-2 in partnership with the Province of Ontario and CanCOGeN, Canada’s viral sequencing effort.
DNAstack powers the Autism Sharing Initiative, an international collaboration creating a globally federated network of genomics, clinical, and other data in autism.
DNAstack is building data and research networks in oncology, rare disease, and other specialty specific areas where precision health will save and improve lives.
GA4GH: International policies and standards for data sharing across genomic research and healthcare
Our products implement open industry standards by the Global Alliance for Genomics & Health.
Neuroscience AI will enable researchers to make discoveries from larger and more diverse datasets than ever before.
The new project will help expand federated, AI-powered insights across distributed networks of genomics and health data.
Award recognizes Toronto company’s global impact on genomics and health research.
DNAstack is developing a new cloud-based network that allows researchers looking to improve our ability to diagnose and treat COVID-19 to share their findings.
The province will work with a made-in-Ontario technology company DNAstack to immediately establish a genomics databank and real-time analytics dashboard to empower the province’s public health officials and improve the government’s planning related to pandemic response.
We work with a global community of precision medicine initiatives, research consortiums, patient advocacy groups, hospitals, startups, funders, pharma companies, and governments to accelerate biomedical research.